Breast Cancer, An Issue of Hematology/Oncology Clinics of North America: The Clinics: Internal Medicine, cartea 37-1
Editat de Harold J. Bursteinen Limba Engleză Hardback – 28 noi 2022
Din seria The Clinics: Internal Medicine
- 5% Preț: 546.14 lei
- 5% Preț: 591.22 lei
- 5% Preț: 403.22 lei
- 5% Preț: 547.09 lei
- 5% Preț: 547.44 lei
- 5% Preț: 518.41 lei
- 5% Preț: 518.62 lei
- 5% Preț: 518.67 lei
- 5% Preț: 518.96 lei
- 5% Preț: 519.44 lei
- 5% Preț: 517.98 lei
- 5% Preț: 519.60 lei
- 5% Preț: 573.62 lei
- 5% Preț: 403.11 lei
- 5% Preț: 402.77 lei
- 5% Preț: 403.05 lei
- 5% Preț: 402.97 lei
- 5% Preț: 388.01 lei
- 5% Preț: 463.34 lei
- 5% Preț: 403.45 lei
- 5% Preț: 460.60 lei
- 5% Preț: 405.53 lei
- 5% Preț: 402.77 lei
- 5% Preț: 460.69 lei
- 5% Preț: 462.57 lei
- 5% Preț: 295.31 lei
- 5% Preț: 448.61 lei
- 5% Preț: 506.70 lei
- 5% Preț: 402.08 lei
- 5% Preț: 402.52 lei
- 5% Preț: 402.52 lei
- 5% Preț: 519.15 lei
- 5% Preț: 518.39 lei
- 5% Preț: 614.05 lei
- 5% Preț: 518.21 lei
- 5% Preț: 518.09 lei
- 21% Preț: 450.00 lei
- 21% Preț: 448.67 lei
- 5% Preț: 576.44 lei
- 5% Preț: 576.17 lei
- 5% Preț: 577.92 lei
- 5% Preț: 576.94 lei
- 5% Preț: 576.11 lei
- 5% Preț: 570.07 lei
- 5% Preț: 547.43 lei
- 5% Preț: 686.25 lei
- 5% Preț: 751.77 lei
- 5% Preț: 576.27 lei
- 5% Preț: 579.22 lei
- 5% Preț: 576.17 lei
Preț: 635.65 lei
Preț vechi: 669.10 lei
-5% Nou
Puncte Express: 953
Preț estimativ în valută:
121.64€ • 126.23$ • 101.67£
121.64€ • 126.23$ • 101.67£
Carte disponibilă
Livrare economică 22 februarie-08 martie
Livrare express 11-15 februarie pentru 37.69 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443181856
ISBN-10: 0443181853
Pagini: 240
Dimensiuni: 152 x 229 x 20 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0443181853
Pagini: 240
Dimensiuni: 152 x 229 x 20 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Disparities in Breast Cancer Outcomes and How to Resolve Them
Testing for Inherited Susceptibility to Breast Cancer
Breast Cancer Pathology in the Era of Genomics
Breast Cancer Pathology in the Era of Genomics
Role of Ovarian Suppression in Early Premenopausal Breast Cancer
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
Biology and Treatment of HER2-Low Breast Cancer
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer
Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Multidisciplinary Management of Brain Metastasis from Breast Cancer
Systemic Therapy for Hereditary Breast Cancers
Evidence-Based Guidance for Breast Cancer Survivorship
Testing for Inherited Susceptibility to Breast Cancer
Breast Cancer Pathology in the Era of Genomics
Breast Cancer Pathology in the Era of Genomics
Role of Ovarian Suppression in Early Premenopausal Breast Cancer
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
Biology and Treatment of HER2-Low Breast Cancer
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer
Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Multidisciplinary Management of Brain Metastasis from Breast Cancer
Systemic Therapy for Hereditary Breast Cancers
Evidence-Based Guidance for Breast Cancer Survivorship